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Summary
The innate immune response plays a crucial role in sat-
isfactory host resolution of bacterial infection. In re-
sponse to chemotactic signals, neutrophils are early
responding cells that migrate in large numbers to sites
of infection. The recent discovery of secreted neutro-
phil extracellular traps (NETs) composed of DNA and
histones opened a novel dimension in our understand-
ingof themicrobial killingcapacityof thesespecialized
leukocytes.M1 serotype strains of thepathogenGroup
A Streptococcus (GAS) are associated with invasive
infections including necrotizing fasciitis (NF) and
express a potent DNase (Sda1). Herewe apply amolec-
ular genetic approach of allelic replacement mutagen-
esis, single gene complementation, and heterologous
expression to demonstrate that DNase Sda1 is both
necessary and sufficient to promote GAS neutrophil
resistance and virulence in a murine model of NF.
Live fluorescent microscopic cell imaging and histo-
pathological analysis are used to establish for the first
time a direct linkage between NET degradation and
bacterial pathogenicity. Inhibition of GAS DNase
activity with G-actin enhanced neutrophil clearance
of the pathogen in vitro and reduced virulence in
vivo. The results demonstrate a significant role for
NETs in neutrophil-mediated innate immunity, and at
the same time identify a novel therapeutic target
against invasive GAS infection.
Results and Discussion
Mutagenesis, Complementation, and Heterologous
Expression of GAS sda1
Neutrophil extracellular traps (NETs) are composed of
DNA and contain chromatin and neutrophil granule com-
ponents, which act to capture and kill surrounding bac-
teria independent of phagocytic uptake [1]. The discov-
ery of NETs and their clear contribution to neutrophil
innate immune function raises an interesting question:
have certain bacterial pathogens evolved mechanisms
to escape NETs in order to enhance their survival within
*Correspondence: vnizet@ucsd.eduthe host? We hypothesized that DNase activity contrib-
uted to virulence of invasive GAS strains by allowing
the organism to escape NET-mediated killing. A well-
recognized phenotype shared by all strains of GAS is
the elaboration of one or more extracellular deoxyribo-
nucleases (DNases) [2, 3]. Long enigmatic, an overall
contribution of DNase production to GAS virulence
was recently demonstrated in the studies of Sumby
et al. [4]. Allelic replacement mutagenesis of wt serotype
M1 GAS strain 5448 targeted the gene encoding Sda1
(see Figure S1 in the Supplemental Data available with
this article online). Sda1 was originally discovered on
proteomic analysis of a globally disseminated invasive
M1T1 GAS clone [5] and encodes the principal extracel-
lular DNase activity [4]. By agarose gel assay, the
M1DSda1 mutant demonstrated a clear decrease in
DNase activity (Figure 1A). DNase activity could be re-
stored to wt levels in the mutant by transformation with
a plasmid (pSda1) bearing the cloned sda1 gene (Fig-
ure 1A), thus excluding polar effects of mutagenesis.
Moreover, the M1DSda1 mutant was equivalent to wt
in expression of secreted cysteine protease SpeB and
surface bound M1 protein (Figure S2A). Wild-type and
DSda1 mutant also possessed equal hemolytic activities
(Figure S2B). Together, these studies exclude pleiotro-
pic mutations on certain virulence factors that promote
GAS phagocyte resistance. Finally, clear increases in
extracellular DNase activity could be appreciated in
a noninvasive serotype M49 isolate of GAS as well as
the nonpathogenic gram-positive bacterium Lactococ-
cus lactis when each was transformed with pSda1
(Figure 1A). A panel of bacterial reagents was thus gen-
erated to test the role of DNase Sda1 in pathogenesis by
means of both loss- and gain-of-function analyses.
GAS DNase Promotes Bacterial Survival
in Neutrophil- and Blood-Killing Assays
To test a potential role of DNase Sda1 in GAS resis-
tance to innate immune clearance, coincubation exper-
iments were performed with bacteria and freshly iso-
lated human neutrophils. The wt M1 GAS strain was
found to be significantly more resistant to neutrophil
killing than the isogenic M1DSda1 mutant at a number
of different bacterial inocula and incubation times (Fig-
ures 1B and 1C). Focusing specifically on extracellular
bactericidal mechanisms including NETs, cytochalasin
D (CytD) was added to block phagocytotic uptake [1],
resulting in a further exaggeration of the survival deficit
of the M1DSda1 mutant (Figure 1D). Expression of
Sda1 in a noninvasive serotype M49 GAS strain con-
ferred enhanced resistance to neutrophil extracellular
killing, a finding echoed in nonpathogenic Lactococcus
lactis transformed with pSda1 (Figure 1D). Taken to-
gether, these data demonstrate that Sda1-mediated
DNase activity is both necessary and sufficient to pro-
mote bacterial resistance to neutrophil killing. Elimina-
tion of Sda1 also rendered GAS more susceptible to
clearance in whole mouse blood (Figure 1E),
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397Figure 1. Expression of DNase Sda1 Pro-
motes Resistance to Neutrophil Killing
(A) Activity of bacterial supernatants in de-
grading calf thymus DNA by agarose gel elec-
trophoresis. Strains tested were wild-type
(wt) M1 GAS, knockout mutant DSda1, com-
plemented knockout mutant transformed
with pSda1 (compl), GAS M49 wt, M49 +
pSda1, Lactococus lactis wt, and L. lactis +
pSda1.
(B and C) Survival of wt M1 GAS and isogenic
DSda1 mutant in coculture with human neu-
trophils (B) at 2 hr at various multiplicity of
infection (moi) or (C) over time (moi = 1.0).
(D) Effect of sda1 expression on GAS M1 (moi
1.0), GAS M49 (moi = 0.5), and Lactococcus
lactis (moi = 1.0) survival of extracellular killing
by human neutrophils (10 mg/ml of the cyto-
chalisin D used to block phagocytosis). Also
shown is survival of GAS M1DSda1 comple-
mented with pSda1 to restore DNase activity.
(E) Surivival of wt M1 GAS and isogenicDSda1
mutant in mouse whole blood. Values re-
ported are means 6 SEM. Results shown
are representative of at least three experi-
ments repeated with similar results.suggesting that DNase expression could contribute to
phagocyte resistance in more complex host tissue
environments.
DNase Sda1 Promotes Virulence in a Mouse
Model of GAS NF
To examine the contribution of the Sda1 DNase to viru-
lence in vivo, we employed a murine model of GAS NF.
Mice challenged subcutaneously with the wt M1 GAS
strain developed significantly larger lesions than those
challenged with an identical dose of the M1DSda1 mu-
tant (Figures 2A and 2B). Upon sacrifice and skin biopsy
5 days postinfection, the lesions of animals infected with
the wt harbored approximately 100-fold greater concen-
trations of viable GAS (CFU/gm) than lesions from mice
infected with the M1DSda1 strain (Figure 2C). Corrobo-
rating findings were provided in challenge experiments
comparing the M49 GAS strain (low baseline DNase ex-
pression) to its counterpart transformed with pSda1.
Overexpression of Sda1 in the GAS M49 background
produced a significant increase in skin lesion size and
bacterial proliferation in vivo (Figures 2A–2C). Thus, ge-
netic manipulation of GAS DNase expression altered vir-
ulence potential in vivo in a fashion that mirrored the ob-
served effects on resistance to neutrophil extracellular
killing ex vivo.GAS DNase Sda1 Promotes Degradation of NETs
We hypothesized that degradation of the DNA frame-
work of NETs could represent the underlying mechanism
to explain the contribution of Sda1 to GAS resistance to
neutrophil killing and virulence potential. To examine this
interaction, we developed assays for real-time visualiza-
tion of NET formation by freshly isolated human neutro-
phils via the Sytox family (Molecular Probes) of fluores-
cent DNA stains. Because these stains do not
penetrate cell membranes effectively, fluorescent DNA
staining is specific to secreted extracellular DNA (e.g.,
NETs) or to nuclear DNA of dead cells. By using this
live-cell imaging technique, we were able to observe dis-
tinct NET formation by isolated neutrophils within 10 min
of isolation. The rapid appearance of NETs supported
the conclusions of Brinkman et al. who concluded that
NET phenomenon is an active process independent of
necrosis or apoptosis by using differential staining of for-
malin-fixed cells [1]. Over the course of 15 min, the wt M1
GAS strain was able to effect a dose-dependent elimina-
tion of NETs, while significant quantities of NETs per-
sisted in companion assays by means of the M1DSda1
mutant. For gain-of-function analysis, we testedL. lactis,
which lacked the ability to eliminate NETs upon coincu-
bation with human neutrophils. Heterologous expres-
sion of GAS Sda1 in L. lactis allowed the transformed
bacteria to degrade NETs (Figure 3A). These studies re-
vealed DNase Sda1 to be necessary and sufficient for
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Bacterial Virulence in a Mouse Model of Nec-
rotizing Fasciitis
(A) CD1 mice were injected subcutaneously in
the flank with 13 106 CFU wild-type (wt) GAS
M1 or M1DSda1 (n = 15 per group), or with 13
107 CFU wt GAS M49 (plasmid control) or
M49 + pSda1 (n = 10 per group). The size of
necrotic skin lesions was measured daily for
5 days. Presence of Sda1 was correlated to in-
creased virulence potential. Values reported
are mean 6 SEM.
(B) Representative photographs of skin
lesions in mice from (A).
(C) Number of bacteria recovered after 5 days
from the site of injection of 13106 CFU of GAS
M1 wt or M1DSda1 mutant, or M49 (plasmid
control) and M49 + pSda1. Data were log10
transformed; bar indicates mean.effective bacterial degradation of NETs and correlated
directly with the respective ability of the various bacterial
strains to survive extracellular killing when coincubated
with neutrophils (Figure 1D).
Additional studies were performed to clarify whether
Sda1-mediated degradation of NETs per se represented
a key pathogenic phenotype in the early stages of GAS
infection in vivo. Biopsies from mice infected with the
wt M1 GAS or the M1DSda1 mutant at 4 hr post subcu-
taneous injection revealed similar levels of neutrophil in-
filtration and early abscess formation (Figure S3A). The
number of recruited leukocytes stimulated by the wt
strain and M1DSda1 mutant was also similar when the
bacteria were implanted into subcutaneous tissue cages
for accurate serial sampling over 72 hr (Figure S3B). Pu-
rulent exudates from the early stages of abscess forma-
tion in the subcutaneous challenge model (4 hr) were
collected for DNA staining to visualize NET formation
in vivo. In each of four mice infected with wt M1 GAS in
which clear exudates of intact neutrophils were col-
lected, no NETs could be visualized (Figure 3B). In con-
trast, NETs were common in the purulent exudates ob-
tained from a group of mice challenged with the
identical inoculum of the M1DSda1 mutant (Figure 3B).
These findings support the mechanistic linkage of GAS
Sda1 DNase-mediated enhancement of bacterial sur-
vival and NET degradation ex vivo (Figures 1B–1E and3A) with enhanced bacterial virulence potential in vivo
(Figure 2).
A DNase Inhibitor Increases GAS Sensitivity
to Neutrophil Killing
The identification of GAS DNase Sda1 degradation of
NETs as a critical element in the pathogen’s ability to re-
sist extracellular killing suggested that neutralization of
this virulence phenotype could render the organism
more susceptible to host neutrophil clearance. As
a proof of concept for pharmacological targeting of
GAS DNase production, we performed total and extra-
cellular (+ CytD) neutrophil killing assays with wt and
M1DSda1 mutant GAS in the presence and absence of
G-actin, a known inhibitor of DNase I activity [6, 7]. Addi-
tion of the DNase inhibitor produced a marked decrease
in the ability of GAS wt M1 strain to resist neutrophil kill-
ing, rendering it equally susceptible to clearance as the
GAS M1DSda1 mutant (Figure 4A). This finding rein-
forced the link between bacterial DNase activity and es-
cape from neutrophil extracellular killing. Further, we ob-
served that the effect of DNase inhibition could be
extended in vivo. Mice were challenged simultaneously
with an equal inoculum of GAS in each flank. In one injec-
tion site, the DNase inhibitor G-actin was simultaneously
introduced, while the opposite received vehicle alone,
allowing each animal to serve as its own control.
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399Figure 3. GAS DNase Sda1 Degrades NETs
In Vitro and In Vivo
(A) Fluorescent images of DNA NETs stained
with Sytox Orange overlaid with a brightfield
image of human neutrophils. Wild-type M1
GAS or M1DSda1, and Lactococcus lactis
(plasmid control) and L. lactis + Sda1 on
a plasmid (pSda1) were cocultured with hu-
man neutrophils. NETs were stained without
fixation after 15 min, appearing bright orange.
Presence of Sda1 was correlated to elimina-
tion of NETs. For quantitation, NETs were
enumerated for each treatment by counting
transects after staining for NETs; a NET was
defined as a discrete area of bright orange
fluorescence larger in size than a neutrophil.
(B) Representative grayscale image of NETs
present in abscess exudates 22 hr after sub-
cutaneous injection of wt M1 GAS or
M1DSda1 mutant. Abscess exudates were
stained with Sytox orange and visualized flu-
orescently. NETs were clearly visualized in
4/4 mice injected with M1DSda1 mutant and
in 0/4 mice injected with wt M1 GAS.We observed that necrotic lesions on the side treated
with G-actin were markedly smaller than the untreated
controls (Figure 4B).
Conclusions
Neutrophils effectively kill bacteria through a variety of
mechanisms involving phagocytosis and/or degranula-
tion, including proteolytic enzymes, antimicrobial pep-
tides, and reactive oxygen and nitrogen species [8].
The landmark study of Brinkmann et al. [1] describing
NETs revealed a novel mechanism by which host neu-
trophils extend their ability to defend against invading
microbes. The authors speculated that within NETs,
antimicrobial peptides and proteases are concentrated
at high levels to effect bacterial killing. The present
work provides the first demonstration of a pathogenic
bacterium facilitating its escape from neutrophil killing
by degradation of NETs, providing complementation
and heterologous expression studies that establish
molecular Koch’s postulates for Sda1 as a virulence
factor.
Over the last three decades, a resurgence of severe in-
vasive forms of GAS infection is well documented, in-
cluding the life-threatening syndromes of necrotizing
fasciitis (NF) and streptococcal toxic shock syndrome
(STSS) [9, 10]. All GAS strains express one or more
DNase genes [2, 3, 11], and it is likely that DNase contrib-
utes in concert with established virulence factors suchas M protein, hyaluronic acid capsule, and streptolysin
S to the overall phagocyte resistance of the pathogen.
It is possible that the unusual potency of phage-en-
coded Sda1 [4, 5] contributes in an important fashion
to the strong epidemiologic association of clonal sero-
type M1 strains with NF and other severe invasive forms
of GAS infections.
We have provided evidence that the marked virulence
attenuation of GAS sda1 mutants can be correlated to
degradation of NETs in vitro and in vivo. As a corollary
to this observation, the phenomenon of NET formation
demonstrated in vitro by Brinkman et al. [1] can now
be appreciated to represent an essential component of
host innate immunity in vivo. As elaboration of DNases
has been documented in several other bacterial species
of clinical significance [2, 12, 13], future studies can be
directed to establish whether degradation and escape
from NETs can represent a more broadly generalized
mechanism of bacterial virulence. In the case of GAS,
our studies indicate that drugs designed to neutralize
DNase activity and preserve host NET integrity could
represent a novel adjunctive therapy to antibiotic and
surgical management.
Supplemental Data
Supplemental Data include three figures and Supplemental Experi-
mental Procedures and are available with this article online at
http://www.current-biology.com/cgi/content/full/16/4/396/DC1/.
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400Figure 4. GAS Sda1 Promotion of GAS Sur-
vival Can Be Reversed by a DNase Inhibitor
(A) The DNase inhibitor G-actin (100 mg/ml)
reduces wt M1 GAS survival in coculture
with human neutrophils to levels seen with
the isogenic M1Dsda1 mutant, both with
and without 10 mg/ml of cytochalasin D to in-
hibit phagocytosis (moi = 0.01, 2 hr). Values
reported are mean + SEM. Results shown
are representative of at least three experi-
ments with similar results.
(B) CD1 mice were injected subcutaneously
in both flanks with 1–2 3 107 CFU wild-type
(wt) GAS M1 with (right flank) or without (left
flank) addition of 165 mg of G-actin (n = 11).
The size of necrotic skin lesions was mea-
sured daily for 3 days. Injection of actin signif-
icantly reduced lesion size (p = 0.0029).
Values reported are mean 6 SEM. Photos of
two representative animals are shown.Acknowledgments
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